Itraconazole inhibits HMEC-1 angiogenesis

Biomedicine and Pharmacotherapy

Volumn 66, Issue 4, 2012, Pages 312-317

  Del Carratore, Renata ^a   Carpi, Angelo ^b   Beffy, Pascale ^a   Lubrano, Valter ^c   Giorgetti, Lucia ^e   Maserti, Bianca Elena ^d   Carluccio, Maria Annunziata ^a   Simili, Marcella ^a   Iervasi, Giorgio ^a   Balzan, Silvana ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Gabriele Monasterio Fondation   (Italy)

^d CNR Consiglio Nazionale delle Ricerche   (Italy)

^e Institute of Agricultural Biology and Biotechnology   (Italy)

Author keywords

Angiogenesis; CYP 51; Endothelial cell; Itraconazole

Indexed keywords

ANGIO ASSOICATED MIGRATORY CELL PROTEIN; CELL PROTEIN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ITRACONAZOLE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN DERMAL MICROVASCULAR ENDOTHELIAL CELL; MICROTUBULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ADULT; ANGIOGENESIS INHIBITORS; ANTIFUNGAL AGENTS; CELL LINE; CHOLESTEROL; ENDOTHELIAL CELLS; HUMANS; ITRACONAZOLE; MICROTUBULES; MICROVESSELS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84862489430     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.11.004     Document Type: Article

References (29)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31.
2. Cavallaro U., Christofori G. Molecular mechanisms of tumor angiogenesis and tumor progression. J Neuro Oncol 2000, 50:63-70.
3. Jain R.K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005, 7:58-62.
4. Lamalice L., Le Boeuf F., Huot J. Endothelial cell migration during angiogenesis. Circ Res 2007, 100:782-794.
5. Fink M., Acimovic J., Režen T., Tanšek N., Rozman D. Cholesterogenic lanosterol 14α-demethylase (CYP51) is an immediate early response gene. Endocrinology 2006, 146:5321-5331.
6. Chong C.R., Chen X., Shi L., Liu J.O., Sullivan D.J. A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2006, 2:415-416.
7. Chong C.R., Xu J., Lu J., Bhat S., Sullivan D.J., Liu J.O. Inhibition of angiogenesis by the antifungal drug itraconazole. ACS Chem Biol 2007, 2:263-270.
8. Wullschleger S., Loewith R., Hall M.N. mTOR signalling in growth and metabolism. Cell 2006, 124:471-484.
9. Xu J., Dang Y., Ren Y.R., Liu J.O. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A 2010, 107:4764-4769.
10. Fingar D.C., Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 2004, 23:3151-3171.
11. Kim J., Tang J.Y., Gong R., Kim J., Lee J.J., Clemons K.V., et al. Itraconazole, a commonly used antifungal that inhibits hedgehog pathway activity and cancer growth. Cancer Cell 2010, l17:388-399.
12. Byrd N., Grabel L. Hedgehog signaling in murine vasculogenesis and angiogenesis. Trends Cardiovasc Med 2004, 14:308-313.
13. Renault M.A., Roncalli J., Tongers J., Thorne T., Klyachko E., Misener S., et al. Sonic Hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells. J Mol Cell Cardiol 2010, 49:490-498.
14. Nanobashvili J., Jozkowicz A., Neumayer C., Fügl A., Sporn E., Polterauer P., et al. Development of 'no-reflow' phenomenon in ischemia/reperfusion injury: failure of active vasomotility and not simply passive vasoconstriction. Endothelial Cells Eur Surg 2003, 35:417-424.
15. Viemann D., Goebeler M., Schmid S., Nordhues U., Klimmek K., Sorg C., et al. TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells. J Leukocyte Biol 2006, 80:174-185.
16. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690.
17. Beffy P., Del Carratore R., Masini M., Furling D., Puymirat J., Masiello P., et al. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts. Int J Biochem Cell Biol 2010, 42:1973-1983.
18. Beffy P., Barsanti C., Del Carratore R., Simi S., Benedetti P.A., Benzi L., et al. Expression and localization of myotonic dystrophy protein kinase in human skeletal muscle cells determined with a novel antibody: possible role of the protein in cytoskeleton rearrangements during differentiation. Cell Biol Int 2005, 29:742-753.
19. Zeng H., Dvorak H.F., Mukhopadhyay D. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 2001, 276:26969-26979.
20. Babaei S., Stewart D.J. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovascular Res 2002, 55:190-200.
21. Beckner M.E., Liotta L.A. AAMP, a conserved protein with immunoglobulin and WD40 domains, regulates endothelial tube formation in vitro. Lab Invest 1996, 75:97-107.
22. Dai J., Peng L., Fan K., Wang H., Wei R., Ji G., et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009, 28:3412-3422.
23. Shen K., Sheng Y., Ji L., Wang Z. Involvement of c-Jun N-terminal kinase and extracellular signal-regulated kinase 1/2 in EGF-induced angiogenesis. Cell Biol Int 2010, 34:1213-1218.
24. Zhu H., Lo H.W. Family of transcription factors in gene regulation and diseases. Curr Genomics 2010, 1:238-245.
25. Caldieri G., Buccione R. Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol 2010, 20:64-70.
26. Ingham P.W. Hedgehog signaling: a tale of two lipids. Science 2001, 30:1879-1881. [Review].
27. Varjosalo M., Taipale J. Hedgehog: functions and mechanisms. Genes Dev 2008, 15:2454-2472.
28. Asai J., Takenaka H., Kusano K.F., Ii M., Luedemann C., Curry C., et al. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 2006, 113:2413-2424.
29. Hua H.E., Hong Z., Bin L.I., Guigang L.I., Zhitao W. Blockade of the Sonic Hedgehog signaling pathway inhibits choroidal neovascularization in a laser-induced rat model. J Huazhong Univ Sci Technol 2010, 30:659-665.